AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 161 min read$VRSK

Mann Elizabeth sold $74K of VRSK

Mann Elizabeth (Chief Financial Officer) sold 400 shares of Verisk Analytics, Inc. (VRSK) at $184.91 on 2026-09-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mann Elizabeth
Published Sep 16, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$VRSK
Neutral
high confidence
Mentioned
$VRSK
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

The sale is modest and pre‑arranged, suggesting limited immediate impact on VRSK's share price.

02

Market read

Insider sell is routine; traders may note but unlikely to act on it.

03

What to watch

Potential upcoming earnings or strategic moves not disclosed could change the relevance of this sale.

Relevance 2/10Novelty 4/10Timing: post‑market 2026‑09‑15

Background

Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

$VRSKNeutralHigh confidence
Context

CFO Elizabeth Mann sold 400 shares of Verisk Analytics for $73,964 via a 10b5‑1 plan, reducing her stake to 17,984 shares.

Expected impact

minimal downward pressure, likely within normal volatility range

Evidence & confidence

Sale size (~$74K) is small relative to market cap; CFO disclosed pre‑arranged plan, indicating no new negative information.

Market effects

Sector

No material impact on the data analytics sector; insider activity is routine.

Regional

Limited to US investors tracking Verisk; no broader regional effect.

Global

Negligible on global markets.

Counterpoint

What could challenge this read

If the CFO's sale signals internal concerns, a short position could be considered despite the small size.

Key entities

  • Company
    Verisk Analytics, Inc.

    Provider of data analytics and risk assessment services.

  • Executive
    Elizabeth Mann

    Chief Financial Officer of Verisk Analytics.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

VRSK insider trading history →

Related articles

SEP 8
$VRSKMed

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

gurufocus.com2 min
AUG 29
$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

simplywall.st2 min
AUG 28
$VRSKMedAI 8/10

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).

finance.yahoo.com3 min
AUG 19
$VRSKMedAI 8/10

Verisk Analytics v. AccuLynx: Sorry, You Actually DO Have To Comply With That Second Request

The Delaware Court of Chancery ordered Verisk Analytics to continue pursuing FTC clearance for its $2.35 billion acquisition of AccuLynx, despite Verisk's attempt to terminate the deal. The court ruled that Verisk's termination was invalid due to its willful conduct in ending negotiations with a competitor, ServiceTitan. Verisk must now comply with a costly Second Request process, which typically takes many months to complete. The court's decision is notable as it is the first to compel a buyer

marketscreener.com2 min